Role of myosin light chain kinase in intestinal epithelial barrier defects in a rat model of bowel obstruction.
BACKGROUND
Bowel obstruction is a common cause of abdominal emergency, since the patients are at increased risk of septicemia resulting in high mortality rate. While the compartmentalized changes in enteric microfloral population and augmentation of bacterial translocation (BT) have already been reported using experimental obstruction models, alterations in epithelial permeability of the obstructed guts has not been studied in detail. Myosin light chain kinase (MLCK) is actively involved in the contraction of epithelial perijunctional actinomyosin ring and thereby increases paracellular permeability. In the current study we attempt to investigate the role of MLCK in epithelial barrier defects using a rat model of simple mechanical obstruction.


METHODS
Wistar rats received intraperitoneal injection of ML-7 (a MLCK inhibitor) or vehicle at 24, 12 and 1 hrs before and 12 hrs after intestinal obstruction (IO). The distal small intestine was obstructed with a single ligature placed 10 cm proximal to the ileocecal junction in IO rats for 24 hrs. Sham-operated rats served as controls.


RESULTS
Mucosal injury, such as villous blunting and increased crypt/villus ratio, was observed in the distal small intestine of IO rats. Despite massive enterocyte shedding, intestinal villi were covered with a contiguous epithelial layer without cell apoptosis. Increased transmural macromolecular flux was noticed in the distal small intestine and the proximal colon after IO. The bacterial colony forming units in the spleen and liver of IO rats were significantly higher than those of sham controls. Addition of ML-7 ameliorated the IO-triggered epithelial MLC phosphorylation, mucosal injury and macromolecular flux, but not the level of BT.


CONCLUSIONS
The results suggest that IO-induced premature enterocytic sloughing and enhanced paracellular antigenic flux were mediated by epithelial MLCK activation. In addition, enteric bacteria may undergo transcytotic routes other than paracellular paths to cross the epithelium.
Wu
Chi-Chin
CC
National Taiwan University College of Medicine, Taipei, Taiwan.
Lu
Yen-Zhen
YZ
Wu
Li-Ling
LL
Yu
Linda C
LC
D000818:Animals; D017209:Apoptosis / Q000235:genetics; D015153:Blotting, Western; D002463:Cell Membrane Permeability / Q000502:physiology*; D004247:DNA / Q000032:analysis; D004195:Disease Models, Animal; D004797:Enzyme-Linked Immunosorbent Assay; D020287:In Situ Nick-End Labeling; D007413:Intestinal Mucosa / Q000378:metabolism*; D007415:Intestinal Obstruction / Q000201:enzymology* / Q000473:pathology; D007421:Intestine, Small / Q000201:enzymology / Q000473:pathology; D008297:Male; D009219:Myosin-Light-Chain Kinase / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar
D004247:DNA; D009219:Myosin-Light-Chain Kinase
Surgery. 2005 Jan;137(1):85-91
15614285
Gastroenterology. 2005 Sep;129(3):902-12
16143130
J Infect Dis. 2006 Jan 15;193(2):241-50
16362888
Am J Pathol. 2006 Jan;168(1):104-14; quiz 363
16400013
Development. 1990 Dec;110(4):1001-20
2100251
J Trauma. 2008 Jun;64(6):1651-64
18545135
J Cell Sci. 2006 May 15;119(Pt 10):2095-106
16638813
Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):11104-9
12960392
Curr Gastroenterol Rep. 2008 Oct;10(5):443-9
18799118
Gastroenterology. 2003 Sep;125(3):795-804
12949725
Curr Biol. 2001 Nov 27;11(23):1847-57
11728307
J Biol Chem. 2004 Dec 31;279(53):55506-13
15507455
Med Clin North Am. 2008 May;92(3):575-97, viii
18387377
J Immunol. 2003 Dec 1;171(11):6164-72
14634132
Lab Invest. 2006 Oct;86(10):1052-63
16909128
Int J Parasitol. 2008 Jul;38(8-9):923-34
18281046
World J Surg. 2007 Sep;31(9):1806-1812
17610111
Am J Pathol. 2005 Feb;166(2):409-19
15681825
J Parasitol. 1990 Jun;76(3):403-9
2191103
Am J Pathol. 2004 Mar;164(3):947-57
14982848
Gastroenterology. 1986 Sep;91(3):673-82
2942438
Infect Immun. 2004 Jun;72(6):3536-42
15155662
Shock. 2003 Apr;19(4):378-82
12688551
J Membr Biol. 1990 Jun;116(2):177-84
2380981
Dis Colon Rectum. 1995 Jun;38(6):640-4
7774478
Mol Biol Cell. 2005 Oct;16(10):5040-52
16055505
J Biol Chem. 2006 Sep 8;281(36):26205-15
16835238
Invest Radiol. 2009 Jun;44(6):329-35
19363446
FASEB J. 2005 Nov;19(13):1822-35
16260652
Gastroenterology. 2002 Oct;123(4):1179-90
12360480
Am J Physiol Gastrointest Liver Physiol. 2000 Nov;279(5):G875-85
11052983
Am J Physiol Gastrointest Liver Physiol. 2003 Jul;285(1):G223-34
12637252
Gastroenterology. 2002 Jul;123(1):163-72
12105845
Gastroenterology. 2000 Dec;119(6):1524-36
11113074
J Invest Surg. 2003 Jan-Feb;16(1):23-8
12554336
Am J Physiol. 1999 Sep;277(3):C554-62
10484342
Am J Surg. 1990 Apr;159(4):394-401
2316803
Arch Surg. 1970 Oct;101(4):478-83
5457245
Am J Physiol Cell Physiol. 2004 Mar;286(3):C693-707
14644769
Ann N Y Acad Sci. 2006 Aug;1072:276-87
17057207
Gastroenterology. 2005 May;128(5):1258-67
15887109
Am J Pathol. 2005 Oct;167(4):1071-9
16192642
Scand J Gastroenterol. 2008;43(9):1030-7
18609165
Ann Surg Oncol. 2001 Sep;8(8):632-7
11569777
BMC Surg. 2002 Aug 13;2:6
12174194
Shock. 2007 Oct;28(4):384-93
17577136